163 related articles for article (PubMed ID: 9352600)
1. Role of T-cell anergy and suppression in susceptibility to IDDM.
Bergerot I; Arreaza G; Cameron M; Chou H; Delovitch TL
Res Immunol; 1997 Jun; 148(5):348-58. PubMed ID: 9352600
[No Abstract] [Full Text] [Related]
2. [Clonal deletion and clonal anergy as the mechanism of self-tolerance induction].
Ota H; Yanagida H; Dobashi H; Ishida H
Nihon Rinsho; 1997 Jun; 55(6):1331-6. PubMed ID: 9200914
[TBL] [Abstract][Full Text] [Related]
3. Anergic T cells as active regulators of the immune response.
Taams LS; Wauben MH
Hum Immunol; 2000 Jul; 61(7):633-9. PubMed ID: 10880733
[TBL] [Abstract][Full Text] [Related]
4. E3 ubiquitin ligases as T cell anergy factors.
Mueller DL
Nat Immunol; 2004 Sep; 5(9):883-90. PubMed ID: 15334084
[TBL] [Abstract][Full Text] [Related]
5. Preservation of self: an overview of E3 ubiquitin ligases and T cell tolerance.
Schartner JM; Fathman CG; Seroogy CM
Semin Immunol; 2007 Jun; 19(3):188-96. PubMed ID: 17403607
[TBL] [Abstract][Full Text] [Related]
6. Immunologic tolerance: development and disruption.
Weigle WO
Hosp Pract (Off Ed); 1995 Feb; 30(2):81-4, 89-92. PubMed ID: 7531711
[TBL] [Abstract][Full Text] [Related]
7. Regulation of peripheral T cell tolerance by the E3 ubiquitin ligase Cbl-b.
Loeser S; Penninger JM
Semin Immunol; 2007 Jun; 19(3):206-14. PubMed ID: 17391982
[TBL] [Abstract][Full Text] [Related]
8. Anergy and suppression as coexistent mechanisms for the maintenance of peripheral T cell tolerance.
Brennan PJ; Saouaf SJ; Greene MI; Shen Y
Immunol Res; 2003; 27(2-3):295-302. PubMed ID: 12857976
[TBL] [Abstract][Full Text] [Related]
9. [Notions on tolerance and autoimmunity. Distinction between self and non-self. Positive and negative thymic selection; peripheric tolerance; consequences for understanding of anergy and autoimmune diseases].
Miossec P
Rev Prat; 1997 May; 47(10):1145-50. PubMed ID: 9208680
[No Abstract] [Full Text] [Related]
10. Strength and Numbers: The Role of Affinity and Avidity in the 'Quality' of T Cell Tolerance.
This S; Valbon SF; Lebel MÈ; Melichar HJ
Cells; 2021 Jun; 10(6):. PubMed ID: 34204485
[TBL] [Abstract][Full Text] [Related]
11. How suppressor cells led to anergy, costimulation, and beyond.
Bour-Jordan H; Bluestone JA
J Immunol; 2009 Oct; 183(7):4147-9. PubMed ID: 19767564
[No Abstract] [Full Text] [Related]
12. The self-nonself discrimination in the context of function.
Cohn M
Theor Med Bioeth; 1998 Sep; 19(5):475-84; discussion 485-504. PubMed ID: 10023195
[No Abstract] [Full Text] [Related]
13. Molecular mechanisms for adaptive tolerance and other T cell anergy models.
Choi S; Schwartz RH
Semin Immunol; 2007 Jun; 19(3):140-52. PubMed ID: 17400472
[TBL] [Abstract][Full Text] [Related]
14. T-cell anergy and altered T-cell receptor signaling: effects on autoimmune disease.
Salojin KV; Zhang J; Madrenas J; Delovitch TL
Immunol Today; 1998 Oct; 19(10):468-73. PubMed ID: 9785671
[TBL] [Abstract][Full Text] [Related]
15. Factors involved in peripheral T cell tolerance: the extent of clonal deletion or clonal anergy depends on the age of the tolerized lymphocytes.
Kuschnaroff LM; De Belder K; Vandeputte M; Waer M
Transpl Int; 1992; 5 Suppl 1():S589-93. PubMed ID: 14621883
[TBL] [Abstract][Full Text] [Related]
16. Uncoupling of anergy from developmental arrest in anti-insulin B cells supports the development of autoimmune diabetes.
Acevedo-Suárez CA; Hulbert C; Woodward EJ; Thomas JW
J Immunol; 2005 Jan; 174(2):827-33. PubMed ID: 15634904
[TBL] [Abstract][Full Text] [Related]
17. [T cell tolerance and autoimmune disease].
Kobayashi S
Nihon Rinsho; 1997 Jun; 55(6):1345-50. PubMed ID: 9200916
[TBL] [Abstract][Full Text] [Related]
18. Efficacy of clonal deletion vs. anergy of self-reactive CD4 T-cells for the prevention and reversal of autoimmune diabetes.
Preda-Pais A; Stan AC; Casares S; Bona C; Brumeanu TD
J Autoimmun; 2005 Aug; 25(1):21-32. PubMed ID: 16005609
[TBL] [Abstract][Full Text] [Related]
19. T-Cell Molecular Modulation Responses in Atherosclerosis Anergy.
Pakzad B; Rajae E; Shahrabi S; Mansournezhad S; Davari N; Azizidoost S; Saki N
Lab Med; 2020 Nov; 51(6):557-565. PubMed ID: 32106301
[TBL] [Abstract][Full Text] [Related]
20. T cell activation and anergy to islet cell antigen in type I diabetes.
Miyazaki I; Cheung RK; Gaedigk R; Hui MF; Van der Meulen J; Rajotte RV; Dosch HM
J Immunol; 1995 Feb; 154(3):1461-9. PubMed ID: 7822811
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
